ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalbán, Frauke Zipp, Ralf Gold et al.|Multiple Sclerosis Journal|2018Cited by 706
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L. Hauser, Ludwig Kappos, Amit Bar‐Or et al.|New England Journal of Medicine|2020Cited by 706
How patients with multiple sclerosis acquire disabilityFred Lublin, Robert A Bermel, Dieter A. Häring et al.|Brain|2022Cited by 532
Clinical Relevance of Brain Volume Measures in Multiple SclerosisNicola De Stefano, Bernd C. Kieseier, Laura Airas et al.|CNS Drugs|2014Cited by 293
<scp>ECTRIMS</scp>/<scp>EAN</scp> guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalbán, Frauke Zipp, Ralf Gold et al.|European Journal of Neurology|2018Cited by 222